Pancand Webinar Series Verification Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pancand webinar series verification study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pancand Webinar Series Verification Study Today - Breaking & Trending Today

Immunovia to Host a Third Webinar in the Series on IMMray PanCan-d: Verification Study and Clinical Use


(1)
LUND, Sweden, Dec. 11, 2020 /PRNewswire/ Immunovia AB (publ) ( Immunovia ), a near-commercial stage diagnostics company developing ground-breaking antibody-based multiplex microarray technology platform called IMMray for the early detection of cancer, today announced that the company will be hosting the third webinar in the series on IMMray PanCan-d, Immunovia s test for early detection of pancreatic cancer. This third webinar will cover IMMray
PanCan-d verification study results and its clinical use including feedback from experts in pancreatic cancer and pancreatic diseases.
Event Details: Webinar No. 3: Immunovia s IMMray PanCan-d Webinar Series Verification Study and Clinical Use
Date and Time: December 17, 2020 at 15:00 CET
Moderator for the Webinar is CEO Patrik Dahlen ....

United States , Immunovia Immray , Immunovia Immray Pancand Webinar , Laura Chirica , Immray Pancan D , Linda Mellby , Patrik Dahlen , Thomas King , School Of Health Professions , Health Translational Cancer Center , Department Of Immuntechnology At Lund University , Rutgers University , Lund University , Vp Research Development , Washington University In St , Health Cancer Center , Department Of Immunotechnology , Pancand Webinar Series Verification Study , Clinical Use , Monday Dec , Medical Director , Molecular Biology , Washington University , Laboratory Director , Adjunct Associate Professor , Health Professions ,